Lista de obras - I Marquez-Rodas - Dominio Público Uruguay

A new era in the treatment of melanoma: from biology to clinical practice.

artículo científico publicado en 2011

A retrospective chart review study describing metastatic melanoma patients profile and treatment patterns in Spain

scientific article published on 21 August 2019

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

artículo científico publicado en 2017

Aldosterone increases RAMP1 expression in mesenteric arteries from spontaneously hypertensive rats.

artículo científico publicado en 2006

CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma

scientific article published on 23 January 2018

Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients

scientific article published on 22 May 2020

Cirrhosis decreases vasoconstrictor response to electrical field stimulation in rat mesenteric artery: role of calcitonin gene-related peptide

artículo científico publicado en 2010

Cost-Effectiveness of Ipilimumab for Previously Untreated Patients with Advanced Metastatic Melanoma in Spain

artículo científico publicado en 2014

Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study.

artículo científico publicado en 2017

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.

artículo científico publicado en 2017

Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients.

artículo científico publicado en 2014

Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene

artículo científico publicado en 2012

Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts.

artículo científico publicado en 2016

Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial

artículo científico publicado en 2017

Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

artículo científico publicado en 2019

Exclusion criteria vs reality: dual BRAF/MEK inhibition and radiotherapy in a patient with melanoma metastatic to the brain and ECOG 3.

artículo científico publicado en 2015

Family History Record and Hereditary Cancer Risk Perception according to National Cancer Institute Criteria in a Spanish Medical Oncology Service: A Retrospective Study ⬇️

artículo científico publicado el 26 de enero de 2012

Five Years of Multidisciplinary Care in Hereditary Cancer: Our Experience in a Spanish University Hospital

artículo científico publicado en 2016

For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive Immunity

scientific article published on 27 September 2018

Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective study.

artículo científico publicado en 2017

Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.

artículo científico publicado en 2016

Highlights of the season 2016–2017 by the Spanish Melanoma Group (GEM).

artículo científico publicado en 2017

Immune checkpoint inhibitors: therapeutic advances in melanoma

artículo científico publicado en 2015

Immunotherapeutic effects of intratumoral nanoplexed poly I:C

artículo científico publicado en 2019

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.

artículo científico publicado en 2018

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors

artículo científico publicado en 2020

Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway

artículo científico publicado en 2007

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Melanoma proteomics suggests functional differences related to mutational status

artículo científico publicado en 2019

Metastatic melanoma with spontaneous regression, psoriasis and HLA-Cw6: case report and a hypothesis to explore.

artículo científico publicado en 2014

MicroRNA expression signatures for the prediction of BRCA1/2 mutation-associated hereditary breast cancer in paraffin-embedded formalin-fixed breast tumors

artículo científico publicado en 2014

MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours

artículo científico publicado en 2013

Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer

artículo científico publicado en 2016

Neratinib (HKI-272) in the treatment of breast cancer.

artículo científico

Neratinib for the treatment of HER2-positive early stage breast cancer.

artículo científico publicado en 2017

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

artículo científico publicado en 2018

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

artículo científico publicado en 2017

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

scientific article published on 30 July 2018

Pathological response in a triple negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann's refined classification.

artículo científico publicado en 2018

Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program.

artículo científico publicado en 2017

Predictive factors of response to immunotherapy-a review from the Spanish Melanoma Group (GEM).

artículo científico publicado en 2017

Primary ovarian Burkitt lymphoma

artículo científico publicado en 2008

Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

scientific article published on 01 May 2019

Protein kinase A increases electrical stimulation-induced neuronal nitric oxide release in rat mesenteric artery.

artículo científico publicado en 2004

Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

scientific article published on 08 April 2019

Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM).

artículo científico publicado en 2017

Review: circulating tumor cells in the practice of breast cancer oncology.

artículo científico publicado en 2015

Ribociclib for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer

artículo científico publicado en 2017

Running away from side effects: physical exercise as a complementary intervention for breast cancer patients.

artículo científico

SEOM clinical guideline for the management of malignant melanoma (2017).

artículo científico publicado en 2017

Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial.

artículo científico publicado en 2015

The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients

artículo científico publicado en 2015

The RANK-RANKL axis: an opportunity for drug repurposing in cancer?

scientific article published on 17 January 2019

The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study.

artículo científico publicado en 2018

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study

artículo científico publicado en 2016

Utility of PET/CT in patients with stage I-III melanoma

artículo científico publicado en 2019

Who detects melanoma? Impact of detection patterns on characteristics and prognosis of patients with melanoma.

artículo científico publicado en 2016

Why do patients with thick melanoma have different outcomes? A retrospective epidemiological and survival analysis.

artículo científico publicado en 2017

[Melanoma of male urethra: A clinical case]

artículo científico publicado en 2010

[Positron emission tomography for the study of solitary pulmonary nodules]

artículo científico publicado en 2008

Cambios epidemiológicos en el melanoma cutáneo: estudio retrospectivo de 969 casos (1996-2010) ⬇️

artículo científico publicado el 5 de agosto de 2012

Lista de obras de I Marquez-Rodas

A new era in the treatment of melanoma: from biology to clinical practice.

A retrospective chart review study describing metastatic melanoma patients profile and treatment patterns in Spain

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

Aldosterone increases RAMP1 expression in mesenteric arteries from spontaneously hypertensive rats.

CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma

Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients

Cirrhosis decreases vasoconstrictor response to electrical field stimulation in rat mesenteric artery: role of calcitonin gene-related peptide

Cost-Effectiveness of Ipilimumab for Previously Untreated Patients with Advanced Metastatic Melanoma in Spain

Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study.

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.

Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients.

Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene

Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts.

Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial

Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

Exclusion criteria vs reality: dual BRAF/MEK inhibition and radiotherapy in a patient with melanoma metastatic to the brain and ECOG 3.

Family History Record and Hereditary Cancer Risk Perception according to National Cancer Institute Criteria in a Spanish Medical Oncology Service: A Retrospective Study ⬇️

Five Years of Multidisciplinary Care in Hereditary Cancer: Our Experience in a Spanish University Hospital

For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive Immunity

Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective study.

Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.

Highlights of the season 2016–2017 by the Spanish Melanoma Group (GEM).

Immune checkpoint inhibitors: therapeutic advances in melanoma

Immunotherapeutic effects of intratumoral nanoplexed poly I:C

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors

Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

Melanoma proteomics suggests functional differences related to mutational status

Metastatic melanoma with spontaneous regression, psoriasis and HLA-Cw6: case report and a hypothesis to explore.

MicroRNA expression signatures for the prediction of BRCA1/2 mutation-associated hereditary breast cancer in paraffin-embedded formalin-fixed breast tumors

MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours

Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer

Neratinib (HKI-272) in the treatment of breast cancer.

Neratinib for the treatment of HER2-positive early stage breast cancer.

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Pathological response in a triple negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann's refined classification.

Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program.

Predictive factors of response to immunotherapy-a review from the Spanish Melanoma Group (GEM).

Primary ovarian Burkitt lymphoma

Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

Protein kinase A increases electrical stimulation-induced neuronal nitric oxide release in rat mesenteric artery.

Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM).

Review: circulating tumor cells in the practice of breast cancer oncology.

Ribociclib for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer

Running away from side effects: physical exercise as a complementary intervention for breast cancer patients.

SEOM clinical guideline for the management of malignant melanoma (2017).

Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial.

The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients

The RANK-RANKL axis: an opportunity for drug repurposing in cancer?

The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study.

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study

Utility of PET/CT in patients with stage I-III melanoma

Who detects melanoma? Impact of detection patterns on characteristics and prognosis of patients with melanoma.

Why do patients with thick melanoma have different outcomes? A retrospective epidemiological and survival analysis.

[Melanoma of male urethra: A clinical case]

[Positron emission tomography for the study of solitary pulmonary nodules]

Cambios epidemiológicos en el melanoma cutáneo: estudio retrospectivo de 969 casos (1996-2010) ⬇️